- Page navigation anchor for RE: The importance of including manufacturers in making language and measurement of contraceptive need indicators more meaningful for measuring fertility intentionsRE: The importance of including manufacturers in making language and measurement of contraceptive need indicators more meaningful for measuring fertility intentions
In GHSP’s February 2022 commentary “Language and Measurement of Contraceptive Need and Making These Indicators More Meaningful for Measuring Fertility Intentions of Women and Girls,” the authors issue a call to action from the Performance, Monitoring and Evidence Working Group (PME-WG) to the broader Family Planning (FP) community (e.g., survey researchers, governments, donors, policy advocates, and program managers) to work toward (1) developing better metrics to improve analysis, policy, and program planning at the country level and (2) testing novel metrics and sharing findings widely. A noticeable omission from the targeted group of stakeholders is manufacturers. These manufacturers include big and small pharmaceutical companies, biotech companies, app developers, companies that currently manufacture contraceptives and devices as well as those who may be interested in contraceptive pharmaceutical and device manufacturing in the future.
Historically, manufacturers have played an important role in shaping and measuring women’s fertility intentions, starting most notably with the advent of oral contraceptive pill Since the introduction of the pill, manufacturers have been responding to women’s reproductive and contraceptive needs by developing different methods including injectable contraceptives, implants, patches and vaginal rings, many of which were supported by USAID and non-governmental organizations (NGO) research.
Increasingly, manufacturers are p...
Show MoreCompeting Interests: None declared.
Submit a Comment to This Article